| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sns-032 | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.31 | phase 1 | inhibitor |
| sns-032 | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.31 | phase 1 | unknown |
| sns-032 | cyclin-dependent kinase 7 | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.82 | investigational,phase 1 | unknown |
| sns-032 | cyclin-dependent kinase 7 | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.82 | investigational,phase 1 | inhibitor |
| sns-032 | cyclin-dependent kinase 9 | NA | Clinical trial target | TTD , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.98 | phase 1 | inhibitor |
| sns-032 | cyclin-dependent kinase 9 | NA | Clinical trial target | TTD , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.98 | phase 1 | unknown |
| sns-032 | vascular endothelial growth factor a | small molecule | NA | drugbank | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | investigational | unknown |
| click here to return to the previous page | ||||||||